These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors. Iwanaga M, Tomonaga M. Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807 [Abstract] [Full Text] [Related]
25. Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples. Choi CW, Lee J, Park KH, Yoon SY, Choi IK, Oh SC, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS. Am J Hematol; 2004 Sep; 77(1):26-30. PubMed ID: 15307102 [Abstract] [Full Text] [Related]
28. Immunoglobulin G subclass analysis in psoriatic arthritis. Haddad A, Thavaneswaran A, Abji F, Pellett F, Chandran V, Wither JE, Gladman DD. J Rheumatol; 2014 Dec; 41(12):2421-4. PubMed ID: 25320220 [Abstract] [Full Text] [Related]
29. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement. Murray D, Kumar SK, Kyle RA, Dispenzieri A, Dasari S, Larson DR, Vachon C, Cerhan JR, Rajkumar SV. Blood Cancer J; 2019 Dec 13; 9(12):102. PubMed ID: 31836698 [Abstract] [Full Text] [Related]
30. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Am J Hematol; 2012 May 13; 87(5):455-60. PubMed ID: 22473809 [Abstract] [Full Text] [Related]
32. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis. Go RS, Gundrum JD, Neuner JM. Clin Lymphoma Myeloma Leuk; 2015 Mar 13; 15(3):177-186.e4. PubMed ID: 25445471 [Abstract] [Full Text] [Related]
34. Monoclonal gammopathy in a tertiary referral hospital. Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ, Jawdat D. Clin Biochem; 2010 Jun 13; 43(9):709-13. PubMed ID: 20206156 [Abstract] [Full Text] [Related]
35. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients. Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O. Am J Hematol; 2011 Jun 13; 86(6):475-8. PubMed ID: 21544856 [Abstract] [Full Text] [Related]
37. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Br J Haematol; 2012 May 13; 157(4):472-5. PubMed ID: 22629552 [Abstract] [Full Text] [Related]
38. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV. N Engl J Med; 2018 Jan 18; 378(3):241-249. PubMed ID: 29342381 [Abstract] [Full Text] [Related]
39. H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study. Soler JA, Güell M, Bricullé M, Gavarró A, Roig I, Sanchez J, Gisbert JP, García P, Villoria A, Calvet X. Ann Hematol; 2009 Aug 18; 88(8):769-73. PubMed ID: 19159929 [Abstract] [Full Text] [Related]